Epogen

Links to news articles on Epogen .

Broward Jury Convicts Man of Fraud in Selling Counterfeit ... -- Mar 28, 2006
...work to legitimize tens of millions in questionable epogen, Procrit and immune globulin, all expensive injectable drugs used by patients with cancer and HIV ... International News Service,

Aranesp dosed every three weeks achieved and maintained target ... -- Mar 28, 2006
...dL in the National Comprehensive Cancer Network® (NCCN) guidelines for "Cancer and Treatment ... is currently marketed in the US by Amgen as EPOGEN® (Epoetin alfa ... RxPG NEWS,

Demand to expand -- Mar 28, 2006
...been found effective in slowing tumor growth in patients with colorectal cancer. ... Rico to boost capacity for drugs produced there -- Epogen, Aranesp, Neupogen ... TMCnet

Bad news for others, good news for Amgen -- Mar 26, 2006
...drug than its predecessor Epogen, has been eating into Epogen's sales as ... patients with kidney failure, but not pursue approval for cancer patients undergoing ... Ventura County Star (subscription),

Biotechs take a stronghold on sales -- Mar 1, 2006
...for kidney-disease-related and chemotherapy-related anemia; Epogen, for anemia ... Genentech's Avastin, for colorectal cancer, saw sales increase 247 percent, to ... Newark Star Ledger,

Amgen's "strategic intention" is to acquire - CEO -- Mar 1, 2006
...it would seek to launch a rival to Amgen's anemia drug for cancer patients two ... Roche claiming Roche's drug Cera infringes on Amgen's patents for Epogen and its ... Reuters

Amgen to expand research unit here -- Mar 2, 2006
Amgen grew from a tiny California start-up in the 1980s on the back of its star drug, Epogen, which treats anemia in cancer patients and patients undergoing ... Boston Globe,

The Best-Selling Drugs In America -- Feb 27, 2006
...injectable medicines used for hard-to-treat diseases like cancer, severe anemia and ... in the US Amgen makes four of them, including Aranesp, Epogen, Neulasta and ... Forbes

Increase ribavirin dose for better HCV treatment response in ... -- Jan 18, 2006
San Francisco, suggests that erythropoietin (EPO, Eprex, NeoRecormon,Procrit, Epogen), a hormone ... for EPO to treat the side-effects of cancer treatments, citing ... Aidsmap,

Amgen CEO expects more Epogen patent battles -- Jan 9, 2006
Johnson (JNJ.N: Quote, Profile, Research), which has rights to sell Epogen under the brand name Procrit in the US as a treatment for cancer patients undergoing ... Reuters

Amgen's blockbuster anemia drugs facing patent challenge -- Dec 24, 2005
Epogen, used by most of the nation's 300,000 dialysis patients, costs about $7,000 to ... are used primarily to treat the anemia caused by cancer chemotherapy and ... Providence Journal (subscription),

Matthew Herper On The Drug Industry -- Dec 27, 2005
...growth hormone, insulin, or Amgen's (nasdaq: AMGN - news - people ) Epogen are likely to ... such as Genentech’s Avastin and Pfizer’s Sutent in breast cancer. ... Forbes

On the threshold of biotech revolution -- Jan 1, 2006
...drugs are expected to go off-patent including blockbusters such as Epogen, Novolin and ... in the discovery of drugs related to diseases such as cancer and diabetes ... Financial Express,

A Biotech Battle Royal -- 23 Dec 2005
Epogen, used by most of the nation's 300,000 dialysis patients, costs about $7,000 to ... are used primarily to treat the anemia caused by cancer chemotherapy and ... New York Times,

Former pharmacy owner sent to prison -- Dec 10, 2005
...medications included anemia drugs Procrit and Epogen. They also included Neupogen, which prevents infections in patients undergoing certain cancer treatments. ... The Journal News.com,

J&J, Amgen Notify Doctors on Anemia Drugs' Disorder (Update2) -- Dec 1, 2005
...time that J&J's changes wouldn't hurt sales of the competing Aranesp and Epogen. ... drugs known as erythropoietins, are used to treat anemia in cancer and kidney ... Bloomberg

Amgen, J&J notify doctors on anemia drugs' disorder -- Dec 6, 2005
Aranesp and Epogen are Amgen's two best-selling drugs. ... The drugs, from a group of drugs known as erythropoietins, are used to treat anemia in cancer and kidney ... Ventura County Star (subscription),

Rx drug law puts Florida at forefront -- Nov 28, 2005
Thus, especially vulnerable patients -- such as those with cancer, transplanted organs or HIV ... drugs, because their pricey medications such as Epogen and Procrit ... Orlando Business Journal,

National Briefs -- Dec 2, 2005
...and Amgen, have notified doctors that the drugs - Aranesp, Epogen and Procrit ... drugs, called erythropoietins, are used to treat anemia in cancer and kidney ... New York Times,

Amgen sues Roche over Epogen patents -- Nov 9, 2005
...a longer-lasting version of Epogen. It is marketed domestically as a treatment for kidney dialysis patients as well as for anemia in cancer patients undergoing ... Reuters

Amgen sues rival for patent violations -- Nov 10, 2005
Epogen is used to treat anemia in kidney failure patients undergoing dialysis in the United States. Longer-lasting Aranesp treats dialysis and cancer patients. ... Ventura County Star (subscription),

Amgen Files Lawsuit Against Roche for Patent Infringement -- Nov 9, 2005
For additional product information, please see www.Epogen.com. ... medicine, helping millions of people around the world in the fight against cancer, kidney disease ... Genetic Engineering News,

Bresagen to Expand Into Mammalian Cell-derived Products -- Nov 8, 2005
...by Psiron are directed at meeting the worldwide need for safe and efficacious cancer therapies. ... Epogen® and Enbrel® are registered trademarks of Amgen Inc. PharmaLive.com (press release),

Amgen stock rises on cancer drug news -- Nov 4, 2005
Trish Hawkins said the drug was the company's most advanced anti-cancer therapy and ... Its top-selling product Epogen, an anemia treatment for patients on dialysis ... CNN

Amgen Announces Sponsorship of World-Class Cycling Event; Company ... -- Nov 2, 2005
...and vital medicines that have helped millions of patients fight cancer, kidney disease and other serious illnesses. Two of these medicines - EPOGEN(R) (Epoetin ... Genetic Engineering News,

Amgen Announces Sponsorship of World-Class Cycling Event; Company ... -- Nov 2, 2005
...vital medicines thathave helped millions of patients fight cancer, kidney disease andother serious illnesses. Two of these medicines - EPOGEN(R) (Epoetinalfa ... Finanzen.net,

STOCK SPOTLIGHT -- Oct 21, 2005
...of Aranesp, used mostly by cancer patients suffering from anemia brought on by chemotherapy, rose 38 percent to $840 million, while sales of Epogen fell 12 ... San Francisco Chronicle,

Data Show Aranesp(R) (Darbepoetin Alfa) Administered Once Monthly ... -- Nov 12, 2005
...which is currently marketed in theU.S. by Amgen as EPOGEN(R) (Epoetin alfa ... helpingmillions of people around the world in the fight against cancer,kidney disease ... Finanzen.net,

EPO drug maker backs cycling race -- Nov 1, 2005
...title sponsor is Amgen Corp., maker of the blood-boosting drugs Epogen and Aranesp ... Amgen sells more than $2 billion of prescription drugs for cancer and kidney ... USA Today

Amgen Beats Estimates But Drops On Revenue Numbers -- Oct 20, 2005
Epogen's sales totaled $599 million, compared to $681 million last year. ... in suppressing pathologic bone turnover in patients with metastatic breast cancer. ... BioWorld Online (subscription),

Amgen earnings quadruple over charges -- Oct 19, 2005
..."Epogen and Aranesp sales do appear light in the quarter," Deutsche Bank analyst ... 66 percent of the chemotherapy market because it forces cancer clinics wanting ... BusinessWeek

Amgen's Third Quarter 2005 Adjusted Earnings Per Share Increased ... -- Oct 19, 2005
Although demand for EPOGEN in the freestanding dialysis clinics remains consistent with ... helps protect patients with most types of cancer undergoing moderately ... Business Wire (press release),

Amgen's earnings quadruple over 2004 -- Oct 20, 2005
..."Epogen and Aranesp sales do appear light in the quarter," Deutsche Bank analyst ... & Johnson's Procrit competes with Aranesp to treat anemia in cancer patients. ... Ventura County Star (subscription),

Amgen Profit Jumps, Revenue Disappoints -- Oct 19, 2005
Sales of Aranesp, which is used to treat anemia in cancer and kidney ... Sales of Epogen fell 12 percent to $599 million, reflecting decreases in wholesaler ... Los Angeles Business Journal,

Amgen 3rd-quarter profit up on drug sales -- Oct 19, 2005
Sales of Aranesp, used to treat anemia in cancer and kidney dialysis patients, rose 38 percent to $840 million, while sales of Epogen, an earlier version of ... Leading The Charge,

Amgen 3rd-Qtr Net Rises to $967 Mln Helped by Aranesp (Update1) -- Oct 19, 2005
...fell 5 percent as sales of its Epogen treatment for anemia in dialysis patients declined. Sales of Aranesp, used to treat anemia in cancer patients undergoing ... Bloomberg

Amgen's Drive to Diversify -- Oct 20, 2005
Neupogen and Neulasta help cancer patients undergoing chemotherapy maintain white blood cell ... And Epogen is indicated for anemia in those with chronic renal ... Motley Fool

SJ stop part of cycling race -- Nov 2, 2005
...undisclosed price to Amgen, a Thousand Oaks biotech company whose discoveries have been used to fight cancer. However, two of its drugs -- Epogen and Aranesp ... San Jose Mercury News,

Amgen's 3rd-Qtr Profit Rose to $967 Mln Helped by Aranesp Sales -- Oct 19, 2005
Epogen, the company's treatment for anemia in dialysis patients, had sales of $599 ... Court in Trenton, New Jersey, alleges that Amgen gave cancer clinics bigger ... Bloomberg

Amgen quarterly profit up, but sales lag -- Oct 19, 2005
Sales of Epogen, an earlier version of Aranesp, decreased 12 percent to $599. ... after a string of impressive successes in clinical studies of its cancer drugs. ... Herald News Daily,

More information on Epogen from the National Cancer Institute

Biological therapy is a type of treatment that works with your immune system. It can help fight cancer or help control side effects (how your body reacts to the drugs you are taking) from other cancer treatments like chemotherapy.

What is the difference between biological therapy and chemotherapy?

Biological therapy and chemotherapy are both treatments that fight cancer. While they may seem alike, they work in different ways. Biological therapy helps your immune system fight cancer. Chemotherapy attacks the cancer cells directly.

How does biological therapy fight cancer?

Doctors are not sure how biological therapy helps your immune system fight cancer. But they think it may:

Stop or slow the growth of cancer cells.
Make it easier for your immune system to destroy, or get rid of, cancer cells.
Keep cancer from spreading to other parts of your body.